VentriPoint Diagnostics (FRA:5V7) Total Stockholders Equity : €0.13 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is VentriPoint Diagnostics Total Stockholders Equity?

VentriPoint Diagnostics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €0.13 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. VentriPoint Diagnostics's Book Value per Share for the quarter that ended in Dec. 2023 was €0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. VentriPoint Diagnostics's Debt-to-Equity for the quarter that ended in Dec. 2023 was 2.17.

VentriPoint Diagnostics Total Stockholders Equity Historical Data

The historical data trend for VentriPoint Diagnostics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics Total Stockholders Equity Chart

VentriPoint Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

-1.69

-1.51

5.76

3.17

0.13

VentriPoint Diagnostics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															3.17	2.31	1.66	0.91	0.13

VentriPoint Diagnostics (FRA:5V7) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

VentriPoint Diagnostics's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0.13	-	0)	/	156.824
	=	0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

VentriPoint Diagnostics's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.079	+	0.203)	/	0.13
	=	2.17

VentriPoint Diagnostics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

VentriPoint Diagnostics (FRA:5V7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (FRA:5V7) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

VPTDF:USA VPT:Canada

Address

18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4

Website

https://www.ventripoint.com

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

VentriPoint Diagnostics (FRA:5V7) Headlines

No Headlines